Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
Meningoencephalitis-like onset of post-infectious AQP4-IgG-positive optic neuritis complicated by GM1-IgG-positive acute polyneuropathy.
Extensive White Matter Dysfunction in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis.
Cytokines as Biomarkers of Treatment Response to IFN β in Relapsing-Remitting Multiple Sclerosis.
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.
Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.
[Antidepressants for treatment of depression in palliative patients : A systematic literature review.]
Risk of venous thrombosis in patients with major illnesses: Results from the MEGA study.
Temporally Consistent Probabilistic Detection of New Multiple Sclerosis Lesions in Brain MRI.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Costs and quality of life in multiple sclerosis patients with spasticity.
Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions.
Diabetes insipidus as a rare cause of acute cognitive impairment in multiple sclerosis.
A possible case of acute disseminated encephalomyelitis after Japanese encephalitis.
Regulatory Effect of 25-hydroxyvitamin D3 on Nitric Oxide Production in Activated Microglia.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Sex-Based Differences in Multiple Sclerosis (Part I): Biology of Disease Incidence.
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
Multiple sclerosis: Biomarkers predict conversion from clinically isolated syndrome to multiple sclerosis.
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis.
No association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica.

Pages